China Boton Group to buy 49% stake in Shandong Ganghong Biotechnology for 160 million yuan
Subsidiary Shenzhen Boton will acquire a 49% equity interest in Shandong Ganghong Biotechnology for 160 million yuan, Reuters reports.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
China Boton Group Co Ltd said its unit Shenzhen Boton has agreed to acquire a 49% equity stake in Shandong Ganghong Biotechnology. The consideration is RMB160 million. The information was published by Reuters.
why it matters
The deal is small and concerns a single company, so it is unlikely to have a broad impact on markets. For investors in China Boton, it mainly signals an expansion of the business through a biotechnology asset.
tags
instruments
sources
- China Boton Group Says Shenzhen Boton To Buy 49% Equity Interest In Target Company For RMB160 Million — Reuters, 13 November 2026 at 10:38 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗